JAK1 (JAK1) ELISA试剂盒产品概述

Full name:
Janus Kinase 1 ELISA试剂盒 (JAK1)
在www.antibodies-online.cn可供23 Janus Kinase 1 (JAK1) ELISA试剂盒的13不同的供货商。 再加上,我们可以发JAK1 抗体 (139)JAK1 蛋白 (14)和数多这个蛋白质的别的产品。 总共184 JAK1产品已列进来了。
AA960307, C130039L05Rik, jak1, JAK1A, JAK1B, JNK, JNK1, JTK3, wu:fb93e10
list all ELISA KIts 基因 基因ID UniProt
JAK1 3716 P23458
JAK1 16451  
JAK1 84598  



适于 JAK1 相互作用对的更多 ELISA 试剂盒

Pig (Porcine) Janus Kinase 1 (JAK1) interaction partners

  1. Porcine reproductive and respiratory syndrome virus -activated TAK-1 (显示 NR2C2 ELISA试剂盒) was essential for the activation of JNK (显示 MAPK8 ELISA试剂盒) and NF-kappaB (显示 NFKB1 ELISA试剂盒) pathways and IL-8 (显示 IL8 ELISA试剂盒) expression.

  2. Data indicate that transmissible gastroenteritis virus (TGEV) infection activates the janus kinase signal transducer and activator of the transcription 1 (JAK (显示 JAK3 ELISA试剂盒)-STAT1 (显示 STAT1 ELISA试剂盒)) signaling pathway.

  3. Data show that proinflammatory cytokines induction was ERK1/2 (显示 MAPK1/3 ELISA试剂盒) and JNK1 (显示 MAPK8 ELISA试剂盒)/2 dependent.

  4. These data suggest that the p38 (显示 MAPK14 ELISA试剂盒) and JNK (显示 MAPK8 ELISA试剂盒) signaling pathways play pivotal roles in PRRSV replication and may regulate immune responses during virus infection.

  5. based on the data, we can conclude that JNK (显示 MAPK8 ELISA试剂盒) plays an active role in fragmentation of pig oocytes and that p38 MAPK (显示 MAPK14 ELISA试剂盒) is not involved in this process

  6. Retinal ischemia-reperfusion alters expression of mitogen-activated protein kinases, particularly ERK1/2 (显示 MAPK1/3 ELISA试剂盒), in the neuroretina and retinal arteries.

  7. PP2A and AIP1 (显示 PDCD6IP ELISA试剂盒) cooperatively induce activation of ASK1 (显示 MAP3K5 ELISA试剂盒)-JNK (显示 MAPK8 ELISA试剂盒) signaling and vascular endothelial cell apoptosis.

  8. Phorbol 12-myristate 13-acetate activation of ERK (显示 MAPK1 ELISA试剂盒) and JNK (显示 MAPK8 ELISA试剂盒) signaling is relevant in the regulation of gene expression during follicular development, ovulation, and luteinization.

Rabbit Janus Kinase 1 (JAK1) interaction partners

  1. This is the first report of the genetic polymorphisms of the JAK1 and STAT3 (显示 STAT3 ELISA试剂盒) genes and their associations with the incidence of non-specific digestive disorder in rabbits.

Human Janus Kinase 1 (JAK1) interaction partners

  1. Multiple myeloma cells over express JAK1/2 and suggest combined chemotherapy with ruxolitinib, bortezomib and lenalidomide to inhibit JAK (显示 JAK3 ELISA试剂盒)/STAT (显示 STAT1 ELISA试剂盒) pathway.

  2. Mechanistic investigations reveal that AJUBA specifically binds the FERM domain of JAK1 to dissociate JAK1 from the IFNgamma recepter, resulting in an inhibition of STAT1 phosporylation and concomitantly its nuclear translocation. Clinically, the level of AJUBA in CRC specimens is negatively correlated with the levels of IFIT2 and pSTAT1

  3. Multilevel genomic analyses of microsatellite instability+ colorectal cancer revealed molecular heterogeneity with clinical relevance, including tumor immunogenicity and a favorable patient outcome associated with JAK1 mutations and the transcriptomic subgroup CMS1

  4. a causal relationship between MLH1 (显示 MLH1 ELISA试剂盒)-deficiency and incidence of oncogenic point mutations in tyrosine kinases driving cell transformation and acquired resistance to kinase-targeted cancer therapies, is reported.

  5. Data show that moringin (GMG-ITC) had a limited inhibitory effect on IFNalpha-induced STAT1 (显示 STAT1 ELISA试剂盒) and STAT2 (显示 STAT2 ELISA试剂盒) activity, indicating differentially targeting JAK (显示 JAK3 ELISA试剂盒)/STAT (显示 STAT1 ELISA试剂盒) signaling pathways.

  6. our studies highlight Jak1 as the first identified substrate for USP6 (显示 USP6 ELISA试剂盒), and they offer a mechanistic rationale for the clinical investigation of Jak (显示 JAK3 ELISA试剂盒) and STAT3 (显示 STAT3 ELISA试剂盒) inhibitors as therapeutics for the treatment of bone and soft tissue tumors along with other neoplasms driven by USP6 (显示 USP6 ELISA试剂盒) overexpression

  7. In this structure, the receptor peptide forms an 85-A-long extended chain, in which both the previously identified box1 and box2 regions bind simultaneously to the FERM and SH2-like domains of JAK1.

  8. Results reveal the structure of box1 from class II cytokine receptors IFNLR1 (显示 IL28RA ELISA试剂盒) and IL10RA (显示 IL10RA ELISA试剂盒) bound to the FERM-SH2 domain of human JAK1, identifying a consensus motif for JAK1 interaction.

  9. study demonstrated that miR (显示 MLXIP ELISA试剂盒)-9 could inhibit activation of the NLRP3 (显示 NLRP3 ELISA试剂盒) inflammasome and attenuate atherosclerosis-related inflammation, likely through the JAK1/STAT1 (显示 STAT1 ELISA试剂盒) signaling pathway. Therefore, miR (显示 MLXIP ELISA试剂盒)-9 may serve as a potential therapeutic target for atherosclerosis.

  10. miR (显示 MLXIP ELISA试剂盒)-340 suppressed HCC (显示 FAM126A ELISA试剂盒) cell proliferation and invasion by regulating the JAK1/STAT3 (显示 STAT3 ELISA试剂盒) pathway

Mouse (Murine) Janus Kinase 1 (JAK1) interaction partners

  1. JAK1-mediated signaling cascades in skin regulate the expression of proteases associated with the maintenance of skin barrier function and demonstrate that perturbation of these pathways can lead to the development of spontaneous pruritic dermatitis.

  2. Small-scale in vivo screening identified several genes, including Cd109 (显示 CD109 ELISA试剂盒), that encode novel pro-metastatic factors. We uncovered signaling mediated by Janus kinases (Jaks) and the transcription factor Stat3 (显示 STAT3 ELISA试剂盒) as a critical, pharmacologically targetable effector of CD109 (显示 CD109 ELISA试剂盒)-driven lung cancer metastasis

  3. a causal relationship between MLH1 (显示 MLH1 ELISA试剂盒)-deficiency and incidence of oncogenic point mutations in tyrosine kinases driving cell transformation and acquired resistance to kinase-targeted cancer therapies, is reported.

  4. High JAK1 expression is associated with Hepatic Fibrosis.

  5. findings demonstrate that clinically relevant doses of the JAK1/2 inhibitor ruxolitinib suppresses the harmful consequences of macrophage overactivation characterizing Hemophagocytic lymphohistiocytosis in 2 murine models.

  6. Data show that CUZD1 (显示 CUZD1 ELISA试剂盒) interacts with a complex containing JAK1/JAK2 (显示 JAK2 ELISA试剂盒) and STAT5 (显示 STAT5A ELISA试剂盒), downstream transducers of prolactin (显示 PRL ELISA试剂盒) signaling in the mammary gland.

  7. JAK1 conditional knockout mice will be an invaluable tool to study cytokine signaling during normal development and disease progression in adult animals.

  8. JAK1, JAK2 (显示 JAK2 ELISA试剂盒), and JAK3 (显示 JAK3 ELISA试剂盒) are involved in stimulation of functional activity of mesenchymal progenitor cells by fibroblast growth factor.

  9. JAK (显示 JAK3 ELISA试剂盒) mediated signaling is involved in the differentiation and proliferation of mesenchymal progenitor cells.

  10. Data indicate thar Janus kinase 1 (Jak1) degradation is dependent on Nedd4 family interacting proteins Ndfip1 (显示 NDFIP1 ELISA试剂盒)/Ndfip2.

Zebrafish Janus Kinase 1 (JAK1) interaction partners

  1. JAK1 activating mutants are insufficient to drive hepatocellular carcinoma development in vivo.

JAK1 抗原简介

Antigen Summary

Janus kinase 1 (JAK1), is a member of a new class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The second phosphotransferase domain bears all the hallmarks of a protein kinase, although its structure differs significantly from that of the PTK and threonine/serine kinase family members. JAK1 is a large, widely expressed membrane-associated phosphoprotein. JAK1 is involved in the interferon-alpha/beta and -gamma signal transduction pathways. The reciprocal interdependence between JAK1 and TYK2 activities in the interferon-alpha pathway, and between JAK1 and JAK2 in the interferon-gamma pathway, may reflect a requirement for these kinases in the correct assembly of interferon receptor complexes. These kinases couple cytokine ligand binding to tyrosine phosphorylation of various known signaling proteins and of a unique family of transcription factors termed the signal transducers and activators of transcription, or STATs.

Alternative names and synonyms associated with JAK1

  • Janus kinase 1 (JAK1) Elisa Kit
  • mitogen-activated protein kinase 8 (MAPK8) Elisa Kit
  • Tyrosine-protein kinase Jak1 (jak1) Elisa Kit
  • Janus kinase 1 (jak1) Elisa Kit
  • Janus kinase 1 (Jak1) Elisa Kit
  • AA960307 Elisa Kit
  • C130039L05Rik Elisa Kit
  • jak1 Elisa Kit
  • JAK1A Elisa Kit
  • JAK1B Elisa Kit
  • JNK Elisa Kit
  • JNK1 Elisa Kit
  • JTK3 Elisa Kit
  • wu:fb93e10 Elisa Kit

Protein level used designations for Janus Kinase 1 (JAK1) ELISA试剂盒

Janus kinase 1 (a protein tyrosine kinase) , protein tyrosine kinase , tyrosine kinase JAK1 , tyrosine-protein kinase JAK1 , janus kinase 1 , Janus kinase 1 , Tyrosine-protein kinase Jak1 , tyrosine-protein kinase JAK1-like , JAK-1 , Janus protein tyrosine kinase 1 , etID309794.6 , fb93e10 , jak-1 , jak1 kinase

442952 Canis lupus familiaris
395681 Gallus gallus
396610 Sus scrofa
677689 Macaca mulatta
697808 Macaca mulatta
743373 Pan troglodytes
100031307 Monodelphis domestica
100286690 Salmo salar
100352594 Oryctolagus cuniculus
100385835 Callithrix jacchus
100433477 Pongo abelii
100473460 Ailuropoda melanoleuca
100559328 Anolis carolinensis
3716 Homo sapiens
16451 Mus musculus
84598 Rattus norvegicus
397202 Sus scrofa
537201 Bos taurus
30280 Danio rerio
JAK1 (JAK1) ELISA试剂盒 精选生产商